Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody

BACKGROUND: Dengue virus (DENV) infection is the most important arthropod- borne viral disease in human, but antiviral therapy and approved vaccines remain unavailable due to antibody-dependent enhancement (ADE) phenomenon. Many studies showed that pre-membrane (prM)-specific antibodies do not effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Ya-Yan, Feng, Jun-Jie, Zhou, Jun-Mei, Yu, Zhi-Zhun, Fang, Dan-Yun, Yan, Hui-Jun, Zeng, Gu-Cheng, Jiang, Li-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765915/
https://www.ncbi.nlm.nih.gov/pubmed/23987307
http://dx.doi.org/10.1186/1471-2180-13-194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765915/
https://www.ncbi.nlm.nih.gov/pubmed/23987307
http://dx.doi.org/10.1186/1471-2180-13-194

Ejemplares similares